Algorithms used in adverse drug event reports: A comparative study

Annals of Pharmacotherapy

Volumn 31, Issue 2, 1997, Pages 164-167

  Frick, Pamela A ^a   Cohen, Louise G ^b,c   Rovers, John P ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DRAKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; ALGORITHM; ARTICLE; COMPARATIVE STUDY; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT;

EID: 0031016847     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100205     Document Type: Article

References (19)

1. Bates DW, Cullen DJ, Laird N, Peterson LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274:29-34.
2. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.
3. Berneker GC, Ciucci AG, Joyce J. Standards for reporting adverse drug reactions (letter), BMJ 1983;287:1720.
4. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977;21:247-54.
5. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions, 1. Background, description and instructions for use. JAMA 1979;242:623-32.
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
7. Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling and reporting. Fam Community Health 1982;5(2):58-67.
8. Naranjo CA, Shear NH, Lanctôt KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol 1992;32:897-904.
9. Pere JC, Begaud B, Haramburu F, Albin H. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmcol Ther 1986;40:451-61.
10. Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. Am J Hosp Pharm 1986;43:1709-14.
11. Busto U, Naranjo CA, Sellers EM, Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol 1982;13:223-7.
12. Rovers JP, Cohen LC. An evaluation of adverse drug reactions published in journals oriented towards clinical pharmacists (abstract). ASHP Midyear Clinical Meeting Abstracts 1988;23:56.
13. Abacus Concepts, Stat View II. Berkley, CA: Abacus Concepts Inc., 1987.
14. Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm 1988;45:1534-9.
15. Corso DM, Pucino F, DeLeo JM, Calls KA, Gallelli JF. Development of a questionnaire for detecting potential adverse drug reactions. Ann Pharmacother 1992;26:890-6.
16. Venulet J. Establishing requirements for the use of terms of reporting adverse drug reactions. Int J Clin Pharm Res 1992;12(2):61-4.
17. Venulet J, Blattner R, von Bulow J, Berneker GC. How good are articles on adverse drug reactions? BMJ 1982;284:252-4.
18. Hutchinson TA, Fiegel KM, HoPingKong H, Bloom WS, Kramer MS, Trummer EG. Reasons for disagreement in the standardized assessment of suspected adverse drug reactions. Clin Pharmacol Ther 1983;34:421-6.
19. Blanc S, Leuenberger P, Berger JP, Brooke EM, Schelling JL. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979;25:493-8.